Posted by Michael Wonder on 23 Feb 2026
EMA publishes agenda for 23-26 February 2026 CHMP meeting
23 February 2026 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue opinions for the following technologies:
- Acoziborole
- Insulin lispro
- Trofinetide
- Insulin aspart
- Iloperidone
- Etanercept
- Influenza and COVID-19 vaccine
- Tovorafenib
- Levodopa with carbidopa monohydrate
- Paltusotine
- Pertuzumab
- Tocilizumab
- Teriparatide
